Suivre
Stephanie Vos
Stephanie Vos
Department of Psychiatry and Neuropsychology, Maastricht University
Adresse e-mail validée de maastrichtuniversity.nl - Page d'accueil
Titre
Citée par
Citée par
Année
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
14722015
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
SJB Vos, C Xiong, PJ Visser, MS Jasielec, J Hassenstab, EA Grant, ...
The Lancet Neurology 12 (10), 957-965, 2013
6112013
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
SJB Vos, F Verhey, L Frölich, J Kornhuber, J Wiltfang, W Maier, O Peters, ...
Brain 138 (5), 1327-1338, 2015
3692015
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ...
Alzheimer's & Dementia 15 (3), 465-476, 2019
3062019
Suspected non-Alzheimer disease pathophysiology—concept and controversy
CR Jack Jr, DS Knopman, G Chételat, D Dickson, AM Fagan, GB Frisoni, ...
Nature Reviews Neurology 12 (2), 117-124, 2016
2732016
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World …
P Lewczuk, P Riederer, SE O’bryant, MM Verbeek, B Dubois, PJ Visser, ...
The world journal of biological psychiatry 19 (4), 244-328, 2018
2452018
Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia
WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ...
JAMA psychiatry 75 (1), 84-95, 2018
1642018
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI
SJB Vos, IA van Rossum, F Verhey, DL Knol, H Soininen, LO Wahlund, ...
Neurology 80 (12), 1124-1132, 2013
1552013
Injury markers predict time to dementia in subjects with MCI and amyloid pathology
IA van Rossum, SJB Vos, L Burns, DL Knol, P Scheltens, H Soininen, ...
Neurology 79 (17), 1809-1816, 2012
1512012
Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design
IA Van Rossum, S Vos, R Handels, PJ Visser
Journal of Alzheimer's Disease 20 (3), 881-891, 2010
1402010
Inflammatory biomarkers in Alzheimer's disease plasma
AR Morgan, S Touchard, C Leckey, C O'Hagan, AJ Nevado-Holgado, ...
Alzheimer's & dementia 15 (6), 776-787, 2019
1372019
Lifestyle for Brain Health (LIBRA): a new model for dementia prevention
OJG Schiepers, S Köhler, K Deckers, K Irving, CA O'Donnell, ...
International journal of geriatric psychiatry 33 (1), 167-175, 2018
1222018
Modifiable risk factors for prevention of dementia in midlife, late life and the oldest-old: validation of the LIBRA index
SJB Vos, MPJ Van Boxtel, OJG Schiepers, K Deckers, M De Vugt, ...
Journal of Alzheimer's Disease 58 (2), 537-547, 2017
1212017
Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum
WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ...
JAMA neurology 79 (3), 228-243, 2022
1082022
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study
IS van Maurik, SJ Vos, I Bos, FH Bouwman, CE Teunissen, P Scheltens, ...
The Lancet Neurology 18 (11), 1034-1044, 2019
1072019
NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers
SJB Vos, BA Gordon, Y Su, PJ Visser, DM Holtzman, JC Morris, ...
Neurobiology of aging 44, 1-8, 2016
1042016
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
I Bos, S Vos, F Verhey, P Scheltens, C Teunissen, S Engelborghs, ...
Alzheimer's & Dementia 15 (5), 644-654, 2019
1032019
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
S Vos, I van Rossum, L Burns, D Knol, P Scheltens, H Soininen, ...
Neurobiology of aging 33 (10), 2272-2281, 2012
1032012
Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics
BM Tijms, J Gobom, L Reus, I Jansen, S Hong, V Dobricic, F Kilpert, ...
Brain 143 (12), 3776-3792, 2020
1022020
Variability of CSF Alzheimer’s disease biomarkers: implications for clinical practice
SJB Vos, PJ Visser, F Verhey, P Aalten, D Knol, I Ramakers, P Scheltens, ...
PloS one 9 (6), e100784, 2014
1022014
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20